Prof. Marcin Chmielewski, Head of the Department of Biopolymer Chemistry at the Institute of Bioorganic Chemistry, is an organic chemist specializing in the chemical synthesis of nucleic acids, with a strong focus on translating scientific innovation into commercially deployable RNA technologies. As the founder and leader of the private company FutureSynthesis sp. z o.o., he develops and implements advanced RNA synthesis solutions, including large-scale solid-phase synthesis platforms, thermolabile polymer supports, and disulfide-based conjugation methods. His commercial achievements include precision RNA mass markers, viral diagnostic assays, microarray technologies, and a reactor system for large-scale DNA/RNA synthesizers. With a strong record of patents, industrial collaborations, and technology implementations across Europe and the US, he effectively bridges high-impact science with practical applications in the RNA therapeutics and diagnostics sectors.

Objective: Pitch, partner and grow – connect with investors, corporates and mentors to accelerate your journey.